How We Started

From the beginning absolute protein quantitation has also been the main the focus of the services offered by MRMP to the scientific community from both private sector and academia.  This includes the development, validation, application and transfer of absolute quantitative assays for specific proteins into the client’s and collaborator’s laboratory.  

In 2017 MRMP moved its operation to Montreal to extend collaborations with researchers from clinical and biomedical organizations. The portfolio of proteomics services offered has been extended over the years and includes in addition to quantitative and clinical proteomics, phosphoproteomics, metabolics/lipidomics and structural proteomics using a variety of techniques e.g. H/D exchange, crosslinking, chemical modification, limited proteolysis combined with computational analysis. Recently MRMP provides spatial proteomics, development and application of ISO and CLIA certified metabolite and protein assays.  

Where Are We Now

In the recent years through joint projects with laboratories from academia and private sector (Agilent Technologies) and support from Genome Canada and Genome Quebec, MRMP developed new technologies and kits for absolute quantitation of human and mouse proteins including PeptiQuant Onco for determining the mutation rate of the 1000 most frequently occurring variants in cancer tumors.  SysQuan is another joint project which also supported by Genome Canada/Genome Quebec and Agilent (since 2025) that has the goal to provide affordable System wide absolute Quantitative proteome analysis for both human and mouse by using isotopically labeled mice.   SysQuan enables the absolute quantitation of 10,000s of proteins in 40+ tissues at a fraction of the cost of current technologies.  Kits from PeptiQuant Onco and the SysQuan product line are being launched at ASMS 2026 in San Diego.